Vera Therapeutics Inc. (VERA)
35.89
+0.90 (2.57%)
Upcoming Events
Latest Headlines
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 4, 2026 4:05 PM - StreetInsider
Vera Therapeutics to Participate at Upcoming Investor Conferences
September 1, 2026 7:30 AM - StreetInsider
Increasing unusual call volume: DKS CCCC IMPP VERA EMBJ GMAB DUST BCS KHC SOLZ SN ANF AI PLAB
August 26, 2026 10:40 AM - StreetInsider
Increasing unusual option volume: DKS VERA CRON BBWI AS ARDX VSTM ENR MAIN EWZ XE
August 26, 2026 3:11 AM - StreetInsider
Vera Therapeutics Inc. (VERA) spreader of 6430 contracts of September 35 and 45 calls, share price up 3.1%
August 25, 2026 3:23 PM - StreetInsider
Form SCHEDULE 13G/A Vera Therapeutics, Inc. Filed by: Kynam Capital Management, LP
August 14, 2026 12:16 PM - SEC Filing
Form 4/A Vera Therapeutics, Inc. For: Jul 07 Filed by: Fordyce Marshall
August 12, 2026 6:43 PM - SEC Filing
Form 4/A Vera Therapeutics, Inc. For: Jun 23 Filed by: Fordyce Marshall
August 12, 2026 6:42 PM - SEC Filing
Form 4/A Vera Therapeutics, Inc. For: May 12 Filed by: Fordyce Marshall
August 12, 2026 6:39 PM - SEC Filing
Vera Therapeutics (VERA) PT Lowered to $80 at Goldman Sachs
August 12, 2026 4:29 PM - StreetInsider
Vera Therapeutics (VERA) PT Lowered to $90 at H.C. Wainwright
August 12, 2026 7:21 AM - StreetInsider
Vera Therapeutics, Inc. (VERA) Tops Q2 EPS by 13c
August 10, 2026 5:22 PM - StreetInsider
Form 10-Q Vera Therapeutics, Inc. For: Jun 30
August 10, 2026 4:12 PM - SEC Filing
Form 8-K Vera Therapeutics, Inc. For: Aug 10
August 10, 2026 4:06 PM - SEC Filing
Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
August 10, 2026 4:05 PM - StreetInsider
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 7, 2026 4:05 PM - StreetInsider
Form SCHEDULE 13G Vera Therapeutics, Inc. Filed by: STATE STREET CORP
August 7, 2026 11:11 AM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: Aug 03 Filed by: Boman Nancy Lee
August 5, 2026 4:18 PM - SEC Filing
Form 3 Vera Therapeutics, Inc. For: Aug 03 Filed by: Boman Nancy Lee
August 5, 2026 4:17 PM - SEC Filing
Form SCHEDULE 13G/A Vera Therapeutics, Inc. Filed by: BlackRock, Inc.
July 30, 2026 11:19 AM - SEC Filing
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 10, 2026 4:05 PM - Globe NewsWire
Form 4 Vera Therapeutics, Inc. For: Jul 07 Filed by: Fordyce Marshall
July 9, 2026 4:45 PM - SEC Filing
Vera Therapeutics names Nancy Boman as chief regulatory officer
July 9, 2026 8:01 AM - StreetInsider
Form 8-K Vera Therapeutics, Inc. For: Jul 09
July 9, 2026 8:00 AM - SEC Filing
Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner
July 9, 2026 8:00 AM - StreetInsider
Vera Therapeutics (VERA) PT Raised to $78 at TD Cowen
July 8, 2026 8:09 AM - StreetInsider
Vera Therapeutics (VERA) Reiterated at Overweight by Cantor Fitzgerald on Trutakna Approval
July 8, 2026 7:47 AM - StreetInsider
Vera Therapeutics (VERA) PT Raised to $76 at Guggenheim
July 8, 2026 6:50 AM - StreetInsider
Vera Therapeutics (VERA) PT Raised to $125 at H.C. Wainwright
July 8, 2026 6:42 AM - StreetInsider
Form 8-K Vera Therapeutics, Inc. For: Jul 07
July 7, 2026 12:46 PM - SEC Filing
FDA grants accelerated approval to Vera Therapeutics' kidney drug
July 7, 2026 12:39 PM - StreetInsider
Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy
July 7, 2026 12:37 PM - Globe NewsWire
Scilex, Vera Therapeutics rise premarket; Strategy gains
July 6, 2026 8:18 AM - StreetInsider
Form 4 Vera Therapeutics, Inc. For: Jun 23 Filed by: Fordyce Marshall
June 24, 2026 4:56 PM - SEC Filing
Form 144 Vera Therapeutics, Inc. Filed by: Fordyce Marshall
June 23, 2026 4:30 PM - SEC Filing
Full Article List
